Table of Contents

• FDA Prohibits Use of Human Anti-Viral Drugs in Poultry [ARCHIVED]
• CVM Adverse Drug Data Show Increase in Reports of Lack of Effectiveness for Heartworm Prevention Drugs [ARCHIVED]
  by Dr. Martine Hartogensis, Veterinary Medical Officer, CVM Promotion and Advertising Liaison, Office of Surveillance and Compliance
• CVM Improves Its Cumulative Adverse Drug Experience Summaries Website [ARCHIVED]
  by Suzanne Sechen, Ph.D., Office of New Animal Drug Evaluation
• Cattle Reproductive Drug Estradiol Cypionate (ECP) Illegal, CVM Reminds Industry [ARCHIVED]
• CVM Participation in Codex Alimentarius: Important for Food Safety as Well as for International Trade [ARCHIVED]
  by Merton Smith, Ph.D., J.D., Special Assistant for International Activities, Center for Veterinary Medicine
• The Codex Process [ARCHIVED]
  by Merton Smith, Ph.D., J.D., Special Assistant for International Activities, Center for Veterinary Medicine
• Beef Hormone Trade Dispute [ARCHIVED]
  by Merton Smith, Ph.D., J.D., Special Assistant for International Activities, Center for Veterinary Medicine
• Federal Agencies Partner With Private Industry for Bioterrorism Vulnerability Assessment [ARCHIVED]
  by Jon F. Scheid, Editor
• Ask CVM - November/December 2005 [ARCHIVED]
• Regulatory Activities - November/December 2005 [ARCHIVED]
• Animal Drug Approvals - November/December 2005 [ARCHIVED]